Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) traded up 10.4% during trading on Thursday . The stock traded as high as $60.00 and last traded at $59.31. 162,677 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 1,205,353 shares. The stock had previously closed at $53.74.
Wall Street Analyst Weigh In
Several research firms recently weighed in on TEM. JPMorgan Chase & Co. increased their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 7th. William Blair assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued an "outperform" rating on the stock. Loop Capital began coverage on Tempus AI in a research note on Tuesday, July 9th. They set a "buy" rating and a $48.00 price objective for the company. Bank of America began coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $41.00 price target for the company. Finally, Piper Sandler assumed coverage on shares of Tempus AI in a research report on Monday, August 12th. They set a "neutral" rating and a $40.00 price target for the company. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $45.56.
Get Our Latest Report on TEM
Tempus AI Stock Performance
The company's fifty day moving average is $45.18.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The business had revenue of $165.97 million during the quarter, compared to analysts' expectations of $159.10 million. Sell-side analysts expect that Tempus AI, Inc. will post -6.51 EPS for the current fiscal year.
Institutional Trading of Tempus AI
A number of hedge funds and other institutional investors have recently made changes to their positions in TEM. NEA Management Company LLC purchased a new stake in shares of Tempus AI during the second quarter valued at $160,048,000. Novo Holdings A S purchased a new stake in Tempus AI during the second quarter valued at about $142,605,000. Revolution Growth Management Company Inc. acquired a new position in shares of Tempus AI in the second quarter worth about $128,133,000. Alphabet Inc. purchased a new position in shares of Tempus AI in the second quarter worth approximately $54,289,000. Finally, Lingotto Investment Management LLP acquired a new stake in shares of Tempus AI during the second quarter valued at approximately $32,685,000.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
